My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 407

    1.

    Trials that matter: can patients with venous thromboembolism be treated with fixed-dose subcutaneous unfractionated heparin?

    Goldhaber SZ, Berkwits M.

    Ann Intern Med. 2006 Dec 19;145(12):929-31. No abstract available. PMID: 17179061 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.

    van Den Belt AG, Prins MH, Lensing AW, Castro AA, Clark OA, Atallah AN, Burihan E.

    Cochrane Database Syst Rev. 2000;(2):CD001100. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD001100. PMID: 10796593 [PubMed - indexed for MEDLINE]Related articles

    3.

    Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.

    Kearon C, Ginsberg JS, Julian JA, Douketis J, Solymoss S, Ockelford P, Jackson S, Turpie AG, MacKinnon B, Hirsh J, Gent M; Fixed-Dose Heparin (FIDO) Investigators.

    JAMA. 2006 Aug 23;296(8):935-42.PMID: 16926353 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.

    Hull RD, Pineo GF, Stein P.

    Int Angiol. 1998 Dec;17(4):213-24. Review.PMID: 10204652 [PubMed - indexed for MEDLINE]Related articles

    5.

    Subcutaneous unfractionated heparin for the treatment of venous thromboembolism.

    Kearon C.

    Curr Opin Pulm Med. 2007 Sep;13(5):398-402. Review.PMID: 17940484 [PubMed - indexed for MEDLINE]Related articles

    6.

    Subcutaneous unfractionated heparin compared with low-molecular-weight heparin for the initial treatment of venous thromboembolism.

    Bernardi E, Prandoni P.

    Curr Opin Pulm Med. 2005 Sep;11(5):363-7. Review.PMID: 16093806 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?]

    Ruiz Manzano J, Monreal M.

    Med Clin (Barc). 1998 Nov 28;111(18):697-9. Spanish. No abstract available. PMID: 9887434 [PubMed - indexed for MEDLINE]Related articles

    8.

    Should patients with venous thromboembolism and cancer be treated differently?

    Smorenburg SM, Hutten BA, Prins MH.

    Haemostasis. 1999 Dec;29 Suppl S1:91-7. Review.PMID: 10629414 [PubMed - indexed for MEDLINE]Related articles

    9.

    The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence.

    Hull RD, Raskob GE, Brant RF, Pineo GF, Valentine KA.

    Arch Intern Med. 1997 Nov 10;157(20):2317-21.PMID: 9361572 [PubMed - indexed for MEDLINE]Related articles

    10.

    Low molecular weight heparin versus unfractionated heparin in the initial treatment of venous thromboembolism.

    Hettiarachchi RJ, Prins MH, Lensing AW, Buller HR.

    Curr Opin Pulm Med. 1998 Jul;4(4):220-5.PMID: 10813237 [PubMed - indexed for MEDLINE]Related articles

    11.

    Weight-based low-molecular-weight heparin versus weight-based intravenous unfractionated heparin.

    Umscheid CA, Agarwal R, Gibson G.

    Ann Intern Med. 2007 Sep 18;147(6):433-4; author reply 434. No abstract available. PMID: 17876030 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    For the initial treatment of venous thromboembolism: are all low-molecular-weight heparin compounds the same?

    van der Heijden JF, Prins MH, Büller HR.

    Thromb Res. 2000 Oct 15;100(2):V121-30.PMID: 11053625 [PubMed - indexed for MEDLINE]Related articles

    13.

    Suboptimal monitoring and dosing of unfractionated heparin in comparative studies with low-molecular-weight heparin.

    Raschke R, Hirsh J, Guidry JR.

    Ann Intern Med. 2003 May 6;138(9):720-3.PMID: 12729426 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The optimal long-term treatment of venous thromboembolism.

    Prandoni P.

    Clin Adv Hematol Oncol. 2004 Nov;2(11):729-32. Review. No abstract available. PMID: 16170889 [PubMed - indexed for MEDLINE]Related articles

    15.

    Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).

    Haas S, Breyer HG, Bacher HP, Fareed J, Misselwitz F, Victor N, Weber J; ECHOS Trial Group.

    Int Angiol. 2006 Dec;25(4):335-42.PMID: 17164738 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Treatment of venous thromboembolism.

    Ageno W.

    Thromb Res. 2000 Jan 1;97(1):V63-72. Review.PMID: 10668809 [PubMed - indexed for MEDLINE]Related articles

    17.

    Fixed-dose versus adjusted-dose low molecular weight heparin for the initial treatment of patients with deep venous thrombosis.

    Harenberg J.

    Curr Opin Pulm Med. 2002 Sep;8(5):383-8. Review.PMID: 12172440 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Treatment of venous thromboembolism]

    Rocha E, Panizo C, Lecumberri R.

    Med Clin (Barc). 2000 Jul 8;115(6):224-35. Review. Spanish. No abstract available. PMID: 11002463 [PubMed - indexed for MEDLINE]Related articles

    19.

    Low-molecular-weight heparin in treatment of venous thromboembolism. An emerging theme.

    Hull RD, Pineo GF.

    Int Angiol. 1998 Sep;17(3):131-4. Review. No abstract available. PMID: 9821024 [PubMed - indexed for MEDLINE]Related articles

    20.

    Treatment of venous thromboembolism.

    Ageno W.

    Int J Hematol. 2002 Aug;76 Suppl 2:40-3. Review.PMID: 12430898 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity